2006, Number 4
<< Back Next >>
Cir Cir 2006; 74 (4)
Hidradenitis suppurativa
Charúa-Guindic L, Maldonado-Barrón R, Avendaño-Espinosa O, Navarrete-Cruces T, Osorio-Hernández RM, Jiménez-Bobadilla B
Language: Spanish
References: 46
Page: 249-255
PDF size: 170.97 Kb.
ABSTRACT
Background: Hidradenitis suppurativa is an inflammatory, chronic and recurrent disease of appocrine glands, located in inguinal, axillar, perineal, perianal areas and scalp.
Objective: To determine the frequency and therapeutic management.
Methods: A retrospective, transverse, and descriptive study was carried out. All patients with hidradenitis suppurativa, and who were managed by the Coloproctology Unit from the Gastroenterology Service of the General Hospital of Mexico City from January 1995 to December 2004, were included.
Results: We reviewed 12,689 files and identified 15 patients (0.12%) with hidradenitis suppurativa; nine fulfilled inclusion criteria.
Conclusions: This is a complex disease with a diagnostic and therapeutic challenge.
REFERENCES
1. Mitchell KM, Beck DE. Hidradenitis suppurativa. Surg Clin North Am 2002;6:1147-1156.
2. Bocchini SF, Habr-Gama A, Kiss DR, Imperiale AR, Araujo SE. Gluteal and perianal hidradenitis suppurativa, surgical treatment by wide excision. Dis Colon Rectum 2003;46:944-949.
3. Von Der Werth JM, Willians HC, Raeburn JA. The clinical genetics of hidradenitis suppurativa revisited. Br J Dermatol 2000;142:947-953.
4. Velpeau A. Aisselle. In: Dictionnaire de médicine, un répertoire général des sciences médicales sous le rapport théorique et pratique. Paris: Bechet jeune; 1839.p.2.
5. Vernuil A. De I’hidrosadénite phlegmoneuse et des abscés sudoripares. Arch Gen Med Paris 1864;114:537-557.
6. Schiefferdecker P. Uber morphologische Sekretionserscheinungen in den ekkrinen Hautdrusen des Mensschen. Arch Dermatol Syph 1921;132:130.
7. Woollard HH. The cutaneous glands of man. J Anat 1930;64:415.
8. Brunsting HA. Hidradenitis suppurativa; abscess of the apocrine sweat glands. Arch Dermatol Syph 1939;39:108.
9. Benerjee AK. Surgical treatment of hidradenitis suppurativa. Br J Surg 1992;79:863-866.
10. Carmen C, Yu W, Cook MG. Hidradenitis suppurativa: a disease of follicular epithelium, rather than apocrine glands. Br J Dermatol 1990;122:763-769.
11. Domonkos AN, Arnold HL, Odom RB, Andrews. Tratado de dermatología. 3ª. ed. España: Salvat; 1987. pp. 1-4
12. Wiltz O, Shoetz Jr. DJ, Murray JJ, Roberts PL, Coller JA, Veidenheimer MC. Perianal hidradenitis suppurativa: the Lahey Clinic experience. Dis Colon Rectum 1990:33:731-734.
13. Corman ML. Colon and Rectal Surgery, 4th ed. Philadelphia: Lippicott-Raven;1998. pp. 224-171.
14. Goligher J. Cirugía del ano, recto y colon. 2ª Ed. Masson; 1987. pp. 205-209.
15. Bendahan J, Paran H, Colman S, Neufeld DM, Freund U. The possible role of Chlamydia trachomatis in perineal suppurative hidradenitis. Eur J Surg 1992;158:213-215.
16. Culp CE. Chronic hidradenitis suppurativa of the anal canal. A surgical skin disease. Dis Colon Rectum 1983;26:669-676.
17. Goldberg S. Fundamentos de cirugía anorrectal. 1a. ed. Limusa Noriega;1990. pp. 429-430.
18. Highet AS, Warren RE, Weekes AJ. Bacteriology and antibiotic treatment of perineal suppurative hidradenitis. Arch Dermatol 1988;124:1047-1051.
19. Gilliland R, Wexner SD. Complicated anorectal sepsis. Surg Clin North Am 1997;77:115-153.
20. Barth JH, Kealey T. Androgen metabolism by isolated human axillary apocrine glands in hidradenitis suppurativa. Br J Dermatol 1991;
21. Barth JH, Laytan AM, Cunliffe WJ. Endocrine factors in pre- and postmenopausal women with hidradenitis suppurativa. Br J Dermatol 1996;134:1057-1059.
22. Mortimer PS, Dawber RPR, Gales MA, Moore RA. Mediation of hidradenitis suppurativa by androgens. Br Med J (Clin Res Ed) 1986;292:245-248.
23. Harrison BJ, Read GF, Hughess LE. Endocrine basis for the clinical presentation of hidradenitis suppurativa. Br J Surg 1988:75:972-975.
24. Fitzsimmons JS, Fitzsimmons EM, Gilbert G. Familial hidradenitis suppurativa: evidence in favor of single gene transmissions. J Med Genet 1984;21:281-285.
25. Jemec GBE. The symptomatology of hidradenitis suppurativa in women. Br J Dermatol 1988;119:345-350.
26. Montgomery JR, White TW, Turner ML. A novel connexin 26 gene mutation associated with features of the keratitis-ichthyosis-deafness syndrome and the follicular occlusion triad. J Am Dermatol 2004;51:377-382.
27. Kurzen H, Jung EG, Hartschuh W, Moll I, Franke WW, Moll R. Forms of epithelia differentiation of draining sinus in acne inversa (hidradenitis suppurativa). Br J Dermatol 1999;141:231-239.
28. Roy MK, Appleton AC, Delicata RJ, Sharma AK, Williams GT, Carey PD. Probable association between hidradenitis suppurativa and Crohn’s disease: significance of epitheloid granuloma. Br J Surg 1997;84:375-375.
29. Ostlere LS, Langtry JA, Mortimer PS, Staughton RCD. Hidradenitis suppurativa in Crohn’s disease. Br J Dermatol 1991;125:384-386.
30. Gower-Rousseau C, Maunoury V, Colombel JF, et al. Hidradenitis suppurativa and Crohn’s disease in two families: a significant association. Am J Gastroenterol 1992;87:928.
31. Burrows NP, Russel JR. Crohn’s disease in association with hidradenitis suppurativa. Br J Dermatol 1992;122:523.
32. Jemec G, Wendelboe P. Topical clindamycin versus systemic tetracycline in the treatment of hidradenitis suppurativa. J Am Acad Dermatol;1998;39:971-974.
33. Gupta AK, Ellis CN, Nickoloff BJ, et al. Oral cyclosporine in the treatment of inflammatory and noninflamatory dermatoses. Arch Dermatol 1990;126:339-350.
34. Leb Wohl B, Spadin AN. Infliximab for the treatment of hidradenitis suppurativa. J Am Acad Dermatol 2003;49:670-672.
35. Katansas KH, Christodoulou DK. Axillary hidradenitis suppurativa successfully treated with infliximab in a Crohn’s disease patient. Am J Gastroenterol 2002;97:2155-2156.
36. Sullivan TP, Kerdel FA, Welsh E, Burdick AE, Kirsner RS. Infliximab for hidradenitis suppurativa. Br J Dermatol 2003;149:1046-1049.
37. Mortimer PS, Dawber RP, Gales MA, et al. A double-blind controlled cross-over trial of cyproterone acetate in females with hidradenitis suppurativa. Br J Dermatol 1986;115:263-268.
38. Brown CF, Gallup DG, Brown VM. Hidradenitis suppurativa of the anogenital region: response to isotretinoin. Am J Obstet Gynecol 1988;158:12-15.
39. Lapins J, Startorius K. Emtestam L. Scanner-assisted carbon dioxide laser surgery: a retrospective follow-up study of patients with hidradenitis suppurativa. J Am Acad Dermatol 2002;47:280-285.
40. Brown SC, Kazzazi N, Lord PH. Surgical treatment of perineal hidradenitis suppurativa with special reference to recognition of the perineal form. Br J Surg 1986;73:978-980.
41. Watson JD. Hidradenitis suppurativa—a clinical review. Br J Plast Surg 1985;38:567-569.
42. Parks RW, Parks TG. Pathogenesis, clinical features and management of hidradenitis suppurativa. Ann R Coll Surg Engl 1997;79:83-89.
43. Rompel R, Petres J. Long-term results of wide surgical excision in 106 patients with hidradenitis suppurativa. Dermatol Surg 2000;
44. Lapins J, Ye W, Nyrèn O, Emtestam L. Incidence of cancer among pa-tients with hidradenitis suppurativa. Arch Dermatol 2001;137:730-734.
Full text